Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 9/20 | 0.46 |
| ▸ | LPL | P06858 | 8/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.46 |
| ▸ | MGLL | Q99685 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 3/20 | 0.35 |
| ▸ | CNR2 | P34972 | 3/20 | 0.35 |
| ▸ | MMP2 | P08253 | 2/20 | 0.33 |
| ▸ | MMP9 | P14780 | 2/20 | 0.33 |
| ▸ | MMP8 | P22894 | 2/20 | 0.33 |
| ▸ | MMP13 | P45452 | 2/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.33 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL374243 | 1.00 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL5809203 | 1.00 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL29383962 | 1.00 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL28537539 | 1.00 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL29460237 | 1.00 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL29453590 | 1.00 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL371497 | 1.00 | LIPG (0.46) | LIPGLPLTRPV1MGLLCA1 | |
| SCHEMBL6446324 | 0.98 | LIPG (0.45) | LIPGLPLTRPV1MGLLCA1 | |
| Ethylene Glycol SCHEMBL588016 | 0.96 | LIPG (0.43) | LIPGLPLTRPV1MGLLCA1 | |
| 1,3-Propanediol SCHEMBL23298331 | 0.94 | LIPG (0.42) | LIPGLPLTRPV1MGLLCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11784305-B2 | Negative electrode including silicon nanoparticles having a carbon coating thereon | GM Global Technology Operations LLC (US) | 2023-10-10 | — | — | US | claimed |
| US-10312505-B2 | Usage of conductive and flexible polymers in lithium batteries | ENWAIR ENERJI TEKNOLOJILERI A.S. (TR) | 2019-06-04 | — | — | US | claimed |
| US-9980668-B2 | Photoluminescent nanostructure-based sensors | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2018-05-29 | — | — | US | claimed |
| US-20180034040-A1 | USAGE OF CONDUCTIVE AND FLEXIBLE POLYMERS IN LITHIUM BATTERIES | ENWAIR ENERJI TEKNOLOJILERI A. S. (TR) | 2018-02-01 | — | — | US | claimed |
| EP-2739977-A1 | PHOTOLUMINESCENT NANOSTRUCTURE-BASED SENSORS | Massachusetts Institute of Technology (US) | 2014-06-11 | — | — | EP | claimed |
| WO-2013019722-A1 | PHOTOLUMINESCENT NANOSTRUCTURE-BASED SENSORS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-02-07 | — | — | WO | claimed |
| US-20130035567-A1 | PHOTOLUMINESCENT NANOSTRUCTURE-BASED SENSORS | NATIONAL SCIENCE FOUNDATION | 2013-02-07 | — | — | US | claimed |
| US-8361484-B2 | Polymer systems for lung volume reduction therapy | AERIS THERAPEUTICS, INC. (US) | 2013-01-29 | — | — | US | claimed |
| US-20100040538-A1 | Polymer Systems for Lung Volume Reduction Therapy | CANADIAN IMPERIAL BANK OF COMMERCE (CA) | 2010-02-18 | — | — | US | claimed |
| EP-2059227-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | Aeris Therapeutics, Inc. (US) | 2009-05-20 | — | — | EP | claimed |
| WO-2008039827-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | AERIS THERAPEUTICS, INC. (US) | 2008-04-03 | — | — | WO | claimed |
| US-20250127046-A1 | COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD FOR PRODUCING SAME, DISPLAY DEVICE, AND LIGHTING DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-04-17 | — | — | US | disclosed |
| US-12043782-B2 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2024-07-23 | — | — | US | disclosed |
| US-11784305-B2 | Negative electrode including silicon nanoparticles having a carbon coating thereon | GM Global Technology Operations LLC (US) | 2023-10-10 | — | — | US | disclosed |
| US-11697707-B2 | Chemical sensors based on carbon nanotubes functionalised by conjugated polymers for analysis in aqueous medium | ECOLE POLYTECHNIQUE (FR) | 2023-07-11 | — | — | US | disclosed |
| WO-2004037886-A1 | CATIONIC WATER-SOLUBLE CONJUGATED POLYMERS AND THEIR PRECURSORS | AGENCY FOR SCIENCE TECHNOLOGY AND RESEARCH (SG) | 2004-05-06 | — | — | WO | disclosed |
| EP-1407500-A1 | ELECTROACTIVE POLYMERS AND DEVICES MADE THEREFROM | DOW GLOBAL TECHNOLOGIES INC. (US) | 2004-04-14 | — | — | EP | disclosed |
| US-20030045642-A1 | Reacting aromatic or heteroaromatic monomers to build indivisual blocks separately, followed by combining indivisual blocks to form a single component block polymer | DEPARTMENT OF THE NAVY | 2003-03-06 | — | — | US | disclosed |
| WO-2003007395-A1 | ELECTROACTIVE POLYMERS AND DEVICES MADE THEREFROM | DOW GLOBAL TECHNOLOGIES INC. (US) | 2003-01-23 | — | — | WO | disclosed |
| US-20020013451-A1 | Blue electroluminescent materials for polymer light-emitting diodes | AGENCY FOR SCIENCE TECHNOLOGY AND RESEARCH (SG) | 2002-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100040538-A1 | Polymer Systems for Lung Volume Reduction Therapy | GFER, MUC1, CTH | LIPG 1131/4885LPL 3998/4885TRPV1 2974/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.